Tatjana Sljapic, MD
Clinical Cardiac Electrophysiology · Brick, NJNPI 1255385845
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Medtronic at 49.7% of the total. Reporting peaked in 2019 at $5,774 and has fallen 76.2% since, to $1,371 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NJ, where the typical reported total is $15,131.
Across 271 payments — averaging $55.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Boston Scientific$3K
- Biotronik Inc.$2K
- Abbott$838
- Sanofi-aventis U.S. LLC$443
- Novartis$244
- plus $1K from 24 others
What the payments were for
- Speaking & faculty fees$4003%
- Grants$2942%
- Travel & lodging$6,40543%
- Food & beverage$7,50550%
- Education$3973%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 68 | $7,448 |
| Boston Scientific | 68 | $2,648 |
| Biotronik Inc. | 21 | $1,969 |
| Abbott | 33 | $838 |
| Sanofi-aventis U.S. LLC | 3 | $443 |
| Novartis | 8 | $244 |
| Pfizer | 13 | $210 |
| Biosense Webster, Inc. | 8 | $201 |
| Novo Nordisk | 7 | $123 |
| Boehringer Ingelheim | 6 | $110 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $91 |
| Amgen | 5 | $86 |
| Altathera Pharmaceuticals LLC | 2 | $73 |
| Johnson & Johnson | 3 | $71 |
| Merck | 3 | $51 |
| Cvrx, Inc. | 3 | $50 |
| Atricure, Inc. | 1 | $48 |
| Acutus Medical, Inc. | 1 | $40 |
| GSK | 2 | $34 |
| Irhythm Technologies, Inc. | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 2 | $26 |
| Cardiva Medical, Inc. | 1 | $25 |
| Globus Medical | 1 | $25 |
| Edwards Lifesciences | 1 | $22 |
| AstraZeneca | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Imperative Care, Inc | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Kestra Medical Technology Services, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Arctic Front$1,591
- Watchman$1,043
- MULTAQ$400
- Azure$298
- GENERAL - THERAPIES$233
- EnSite Precision Cardiac Mapping System$153
- LEQVIO$119
- Cobalt$114
How this compares
$15,001 in reported general payments places this provider in the 45th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 13 | $271,387 |
| EliquisApixaban | 181 | $173,647 |
| XareltoRivaroxaban | 31 | $42,676 |
| EntrestoSacubitril/Valsartan | 27 | $24,780 |
| FarxigaDapagliflozin Propanediol | 19 | $24,215 |
| BrilintaTicagrelor | 27 | $19,529 |
| Metoprolol Succinate | 145 | $2,711 |
| Amiodarone Hcl | 71 | $2,191 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 16 | $1,441 |
| Bisoprolol Fumarate | 52 | $1,310 |
| Flecainide Acetate | 36 | $1,300 |
| Atorvastatin Calcium | 53 | $770 |
| Rosuvastatin Calcium | 53 | $695 |
| Potassium Chloride | 17 | $618 |
| Amlodipine Besylate | 54 | $612 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Eliquis | $210 | $445,034194 claims |
| AstraZenecaFarxiga, Brilinta | $20 | $43,74446 claims |
| Johnson & JohnsonXarelto | $71 | $42,67631 claims |
| NovartisEntresto | $244 | $24,78027 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Brick
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
- Arjun TheerthamParlin$102K
- Michael LinkGalloway$96K
- Grant SimonsEnglewood$93K
- Jonathan SteinbergRidgewood$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.